Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy
Background. Recently, immunotherapies have been approved for advanced muscle invasive bladder cancer (MIBC) treatment, but only a small fraction of MIBC patients could achieve a durable drug response. Our study is aimed at identifying tumor microenvironment (TME) subtypes that have different immunot...
Saved in:
| Main Authors: | Zhifeng Wang, Xiqing Li, Xiaoqing Wang, Jie Liu, Lingdian Wang, Wei Wei, Xiaoyu Duan, Degang Ding |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/6737241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant immunotherapy driven bladder preservation for muscle invasive bladder cancer
by: Jiao Hu, et al.
Published: (2025-08-01) -
Multi-machine learning model based on radiomics features to predict prognosis of muscle-invasive bladder cancer
by: Bin Wang, et al.
Published: (2025-07-01) -
Molecular genetic subtypes of non-muscle-invasive bladder cancer: their impact on disease prognosis
by: Sh. M. Sargsian, et al.
Published: (2025-07-01) -
Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer
by: Wei He, et al.
Published: (2025-07-01) -
Impact of regular cystoscopy on prognosis in non–muscle-invasive bladder cancer: A nationwide study
by: Jeong-Soo Kim, et al.
Published: (2025-07-01)